Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia
Phase 4
Recruiting
- Conditions
- S. aureus bacteremiaS. aureus bloodstream infection10004018
- Registration Number
- NL-OMON54379
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 396
Inclusion Criteria
Adults with methicillin-sensitive complicated S. aureus bacteremia;
satisfactory clinical response to initial treatment.
Exclusion Criteria
Patients with a significant undrained abscess; infected prosthetic material;
pregnant/lactating.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome is success of therapy at 180 days after randomization,<br /><br>defined as 1) patient alive and 2) no evidence of microbiologically confirmed<br /><br>disease relapse. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcomes will include antibiotic-related toxicity, length of hospital<br /><br>admission, perceived quality of life and societal costs.</p><br>